High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased char...
Saved in:
| Published in: | Gut Vol. 69; no. 4; pp. 691 - 703 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BMJ Publishing Group Ltd and British Society of Gastroenterology
01.04.2020
BMJ Publishing Group LTD BMJ Publishing Group |
| Series: | Original research |
| Subjects: | |
| ISSN: | 0017-5749, 1468-3288, 1468-3288 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.DesignThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.ResultsWe discovered that a previously unappreciated innate lymphocyte population (Lin–CD7+CD127–CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.ConclusionThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting. |
|---|---|
| AbstractList | ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.DesignThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.ResultsWe discovered that a previously unappreciated innate lymphocyte population (Lin–CD7+CD127–CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.ConclusionThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting. A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.OBJECTIVEA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC.Thirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.DESIGNThirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence.We discovered that a previously unappreciated innate lymphocyte population (Lin-CD7+CD127-CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.RESULTSWe discovered that a previously unappreciated innate lymphocyte population (Lin-CD7+CD127-CD56+CD45RO+) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103+CD69+) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR+CD38+PD-1+) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes.This work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting.CONCLUSIONThis work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting. A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled local and systemic immune profiles in patients with colorectal cancer (CRC) by high-dimensional analysis to provide an unbiased characterisation of the immune contexture of CRC. Thirty-six immune cell markers were simultaneously assessed at the single-cell level by mass cytometry in 35 CRC tissues, 26 tumour-associated lymph nodes, 17 colorectal healthy mucosa and 19 peripheral blood samples from 31 patients with CRC. Additionally, functional, transcriptional and spatial analyses of tumour-infiltrating lymphocytes were performed by flow cytometry, single-cell RNA-sequencing and multispectral immunofluorescence. We discovered that a previously unappreciated innate lymphocyte population (Lin CD7 CD127 CD56 CD45RO ) was enriched in CRC tissues and displayed cytotoxic activity. This subset demonstrated a tissue-resident (CD103 CD69 ) phenotype and was most abundant in immunogenic mismatch repair (MMR)-deficient CRCs. Their presence in tumours was correlated with the infiltration of tumour-resident cytotoxic, helper and γδ T cells with highly similar activated (HLA-DR CD38 PD-1 ) phenotypes. Remarkably, activated γδ T cells were almost exclusively found in MMR-deficient cancers. Non-activated counterparts of tumour-resident cytotoxic and γδ T cells were present in CRC and healthy mucosa tissues, but not in lymph nodes, with the exception of tumour-positive lymph nodes. This work provides a blueprint for the understanding of the heterogeneous and intricate immune landscape of CRC, including the identification of previously unappreciated immune cell subsets. The concomitant presence of tumour-resident innate and adaptive immune cell populations suggests a multitargeted exploitation of their antitumour properties in a therapeutic setting. |
| Author | Lelieveldt, Boudewijn P F Ijsselsteijn, Marieke E Peeters, Koen C M J Abdelaal, Tamim Höllt, Thomas van der Breggen, Ruud de Vries, Natasja L Farina Sarasqueta, Arantza Mahfouz, Ahmed van Unen, Vincent Koning, Frits de Miranda, Noel F C C |
| AuthorAffiliation | 2 TECObiosciences GmbH , Landshut , Germany 1 Immunohematology and Blood Transfusion , Leiden University Medical Center , Leiden , Netherlands 7 Computer Graphics and Visualization , Delft University of Technology , Delft , The Netherlands 3 Pathology , Leiden University Medical Center , Leiden , The Netherlands 6 Surgery , Leiden University Medical Center , Leiden , The Netherlands 4 Pattern Recognition and Bioinformatics , Delft University of Technology , Delft , The Netherlands 5 Leiden Computational Biology Center , Leiden University Medical Center , Leiden , The Netherlands 8 LKEB Radiology , Leiden University Medical Center , Leiden , The Netherlands |
| AuthorAffiliation_xml | – name: 8 LKEB Radiology , Leiden University Medical Center , Leiden , The Netherlands – name: 4 Pattern Recognition and Bioinformatics , Delft University of Technology , Delft , The Netherlands – name: 1 Immunohematology and Blood Transfusion , Leiden University Medical Center , Leiden , Netherlands – name: 7 Computer Graphics and Visualization , Delft University of Technology , Delft , The Netherlands – name: 2 TECObiosciences GmbH , Landshut , Germany – name: 3 Pathology , Leiden University Medical Center , Leiden , The Netherlands – name: 5 Leiden Computational Biology Center , Leiden University Medical Center , Leiden , The Netherlands – name: 6 Surgery , Leiden University Medical Center , Leiden , The Netherlands |
| Author_xml | – sequence: 1 givenname: Natasja L orcidid: 0000-0003-4966-7036 surname: de Vries fullname: de Vries, Natasja L organization: TECObiosciences GmbH, Landshut, Germany – sequence: 2 givenname: Vincent surname: van Unen fullname: van Unen, Vincent organization: Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands – sequence: 3 givenname: Marieke E surname: Ijsselsteijn fullname: Ijsselsteijn, Marieke E organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 4 givenname: Tamim surname: Abdelaal fullname: Abdelaal, Tamim organization: Leiden Computational Biology Center, Leiden University Medical Center, Leiden, The Netherlands – sequence: 5 givenname: Ruud surname: van der Breggen fullname: van der Breggen, Ruud organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 6 givenname: Arantza surname: Farina Sarasqueta fullname: Farina Sarasqueta, Arantza organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 7 givenname: Ahmed surname: Mahfouz fullname: Mahfouz, Ahmed organization: Leiden Computational Biology Center, Leiden University Medical Center, Leiden, The Netherlands – sequence: 8 givenname: Koen C M J surname: Peeters fullname: Peeters, Koen C M J organization: Surgery, Leiden University Medical Center, Leiden, The Netherlands – sequence: 9 givenname: Thomas surname: Höllt fullname: Höllt, Thomas organization: Computer Graphics and Visualization, Delft University of Technology, Delft, The Netherlands – sequence: 10 givenname: Boudewijn P F surname: Lelieveldt fullname: Lelieveldt, Boudewijn P F organization: LKEB Radiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 11 givenname: Frits surname: Koning fullname: Koning, Frits organization: Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands – sequence: 12 givenname: Noel F C C surname: de Miranda fullname: de Miranda, Noel F C C organization: Pathology, Leiden University Medical Center, Leiden, The Netherlands |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31270164$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1uEzEUhS1URNPCC7BAI7FhM8XXHv9tkFAFLVIlNrC2PI4ncTRjF9sTKW9fh7QBuojwxrL8netzfc8FOgsxOITeAr4CoPzjai6bMLYEg2opSC7IC7SAjsuWEinP0AJjEC0TnTpHFzlvMMZSKniFzikQgYF3C7S-9at1u_STC9nHYMbG7kqcXEneNqaed9nnJg6NjWNMzpY9YYJ1qUlu68yYmxC3bmwmt_SmxPQbNqH4Mk9xTo2fpjn4snuNXg6Vdm8e90v08-uXH9e37d33m2_Xn-_anmMo7dAJxyxw7OhSMjb0CvdCmoEJ1hvMbE-Zco7AQEhv3dANhgDugS0pBguqo5fo06Hu_dxXT9aFksyo75OfTNrpaLz-9yb4tV7FrRaYU6pULfDhsUCKv2aXi558tm4cTXBxzpoQRgiva4--f4Zuasv107KmIDhWHZH8FEWoIByYwlCpd3_7Php-GlUFyAGwKeac3HBEAOt9HvQhD3qfB33IQxXJZyLriyl10rV3P56WtgdpP23-76mrP_yxwxOCB_-o260 |
| CitedBy_id | crossref_primary_10_1038_s41385_021_00467_7 crossref_primary_10_1007_s00262_020_02540_9 crossref_primary_10_5306_wjco_v12_i4_238 crossref_primary_10_1038_s41421_023_00605_4 crossref_primary_10_31083_j_fbl2903098 crossref_primary_10_3390_cancers13184708 crossref_primary_10_1002_cac2_12469 crossref_primary_10_3390_cancers12123705 crossref_primary_10_1053_j_gastro_2021_06_064 crossref_primary_10_3389_fimmu_2019_02534 crossref_primary_10_3390_cancers13030559 crossref_primary_10_1136_gutjnl_2020_322101 crossref_primary_10_1038_s41598_024_78908_z crossref_primary_10_3389_fimmu_2022_1032314 crossref_primary_10_1038_s41467_024_51025_1 crossref_primary_10_3389_fonc_2020_01254 crossref_primary_10_3389_fonc_2021_819505 crossref_primary_10_1172_JCI137181 crossref_primary_10_1186_s13073_019_0662_6 crossref_primary_10_3389_fonc_2023_1067305 crossref_primary_10_1016_j_jtos_2022_04_008 crossref_primary_10_3389_fimmu_2022_1003626 crossref_primary_10_1038_s41588_022_01088_x crossref_primary_10_1002_JLB_5MR0722_777R crossref_primary_10_1007_s00259_023_06485_w crossref_primary_10_1016_j_intimp_2025_114799 crossref_primary_10_1097_CJI_0000000000000357 crossref_primary_10_1038_s41423_022_00901_1 crossref_primary_10_1080_14760584_2023_2268724 crossref_primary_10_1136_jitc_2022_004638 crossref_primary_10_3390_ijms252010944 crossref_primary_10_1136_jitc_2022_004717 crossref_primary_10_3389_fimmu_2025_1578444 crossref_primary_10_1002_ctm2_253 crossref_primary_10_1016_j_canlet_2021_12_022 crossref_primary_10_1111_imr_12925 crossref_primary_10_3390_cancers14092241 crossref_primary_10_3390_cancers12113440 crossref_primary_10_1016_j_critrevonc_2025_104931 crossref_primary_10_1016_j_mam_2021_100967 crossref_primary_10_1080_21645515_2021_2024416 crossref_primary_10_1155_2022_9157455 crossref_primary_10_3390_ijms23010124 crossref_primary_10_1016_j_it_2022_04_010 crossref_primary_10_1002_jbm_a_37359 crossref_primary_10_1111_1751_2980_70001 crossref_primary_10_1016_j_isci_2024_110754 crossref_primary_10_1136_gutjnl_2020_320908 crossref_primary_10_3389_fimmu_2019_03080 crossref_primary_10_1038_s41590_023_01429_w crossref_primary_10_1186_s12957_023_03009_6 crossref_primary_10_3389_fimmu_2023_1098847 crossref_primary_10_1126_sciimmunol_abd3489 crossref_primary_10_3390_ijms23147859 crossref_primary_10_1111_imr_12916 crossref_primary_10_1002_eji_202149759 crossref_primary_10_1158_2326_6066_CIR_21_0137 crossref_primary_10_1158_2159_8290_CD_20_0987 crossref_primary_10_1055_a_1472_2730 crossref_primary_10_1002_ctm2_70175 crossref_primary_10_1016_j_bbamcr_2022_119266 crossref_primary_10_3390_cancers13215440 crossref_primary_10_1038_s43018_025_00948_9 crossref_primary_10_1177_03000605221109382 crossref_primary_10_1002_hed_27774 crossref_primary_10_3389_fimmu_2022_803097 crossref_primary_10_3390_jpm14010108 crossref_primary_10_3389_fimmu_2022_959705 crossref_primary_10_1016_j_smim_2022_101670 crossref_primary_10_3389_fimmu_2022_1011590 crossref_primary_10_1136_gutjnl_2022_327496 crossref_primary_10_4132_jptm_2020_05_15 crossref_primary_10_1002_cyto_a_24480 crossref_primary_10_3389_fimmu_2023_1119383 crossref_primary_10_3390_cells11071062 crossref_primary_10_1016_j_intimp_2023_110733 crossref_primary_10_1016_j_smim_2020_101415 crossref_primary_10_3389_fcell_2022_915654 crossref_primary_10_1016_j_intimp_2023_111381 crossref_primary_10_1186_s13045_024_01549_2 crossref_primary_10_3389_fimmu_2019_03111 crossref_primary_10_1111_imr_13319 crossref_primary_10_3390_vaccines10071033 crossref_primary_10_3389_fimmu_2020_01466 crossref_primary_10_1038_s41586_022_05593_1 crossref_primary_10_1097_CM9_0000000000002781 crossref_primary_10_1164_rccm_202303_0442OC crossref_primary_10_3389_fimmu_2023_1171826 crossref_primary_10_3389_fimmu_2022_957436 |
| Cites_doi | 10.1016/j.cell.2017.04.016 10.1158/1078-0432.CCR-11-1997 10.1158/1078-0432.CCR-17-2257 10.1038/s41586-018-0130-2 10.1038/nbt.3973 10.1158/2326-6066.CIR-14-0239 10.1016/j.it.2012.02.010 10.1111/cgf.12893 10.1126/science.aan6733 10.1084/jem.178.2.597 10.1002/0471142956.cy1017s53 10.1002/cyto.a.23738 10.1016/1074-7613(95)90025-X 10.1038/nm.3967 10.1016/j.celrep.2014.09.045 10.1016/j.ccell.2015.06.012 10.1038/nature11252 10.1038/mi.2015.69 10.1200/PO.18.00321 10.1200/JCO.2017.35.15_suppl.3033 10.1158/1078-0432.CCR-18-1749 10.1016/j.immuni.2013.02.010 10.4049/jimmunol.1402711 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U 10.1016/j.immuni.2016.11.005 10.1038/s41416-019-0421-x 10.1111/cgf.12878 10.1186/1471-2407-7-33 10.1186/s13059-015-0620-6 10.1038/s41591-018-0057-z 10.1016/j.cels.2017.12.001 10.1158/0008-5472.CAN-16-3167 10.1126/science.aaa1348 10.1002/cjp2.113 10.1126/science.1129139 10.1016/j.cell.2016.01.002 10.1158/0008-5472.CAN-05-0044 10.1038/16717 10.1038/nbt.4096 10.1093/biostatistics/kxj037 10.1038/ng.3818 10.1056/NEJMoa1003466 10.1038/s41467-018-05072-0 10.1038/labinvest.3700055 10.1084/jem.20171934 10.1016/j.cell.2017.05.035 10.3389/fimmu.2012.00258 10.1002/eji.201040959 10.1053/j.gastro.2018.08.030 10.1038/s41467-017-01689-9 10.1140/epjb/e2013-40829-0 10.1038/363558a0 10.1158/1078-0432.CCR-13-1877 10.1056/NEJMoa1200690 10.1021/ac901049w 10.1101/316034 10.1007/s10479-011-0841-3 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/gutjnl-2019-318672 |
| DatabaseName | BMJ Open Access Journals (Free internet resource, activated by CARLI) BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student MEDLINE - Academic MEDLINE ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-3288 |
| EndPage | 703 |
| ExternalDocumentID | PMC7063399 31270164 10_1136_gutjnl_2019_318672 gutjnl |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Netherlands |
| GeographicLocations_xml | – name: Netherlands |
| GrantInformation_xml | – fundername: ZonMw funderid: http://dx.doi.org/10.13039/501100001826 – fundername: KWF Kankerbestrijding funderid: http://dx.doi.org/10.13039/501100004622 – fundername: American Association for Cancer Research funderid: http://dx.doi.org/10.13039/100000043 – fundername: Nederlandse Organisatie voor Wetenschappelijk Onderzoek funderid: http://dx.doi.org/10.13039/501100003246 – fundername: H2020 Marie Skłodowska-Curie Actions funderid: http://dx.doi.org/10.13039/100010665 – fundername: ; |
| GroupedDBID | --- .55 .VT 08G 0R~ 18M 29I 2WC 39C 4.4 40O 53G 5GY 5VS 7X7 7~S 88E 88I 8AF 8F7 8FE 8FH 8FI 8FJ 9YT AAHLL AAOJX AAUVZ AAWJN AAYEP ABAAH ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACMMV ACOFX ACTZY ADBBV ADFRT ADUGQ AENEX AFKRA AFWFF AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBNVY BENPR BHPHI BLJBA BOMFT BPHCQ BTHHO BVXVI C45 CCPQU CS3 CXRWF DU5 DWQXO E3Z EBS EJD F5P FD8 FYUFA GNUQQ H13 HAJ HCIFZ HMCUK HZ~ IAO IH2 IOF L7B LK8 M1P M2P M7P N9A NXWIF O9- OVD P2P PHGZT PQQKQ PROAC PSQYO RHI RMJ RPM RV8 TEORI TR2 UKHRP UYXKK V24 VM9 VVN WH7 X7M YFH YOC YQY ZY1 .GJ 354 3O- 8R4 8R5 AAKAS ACOAB ACQSR ADCEG ADZCM AGQPQ AI. ASPBG AVWKF AZFZN BTFSW C1A CAG COF DIK FEDTE GX1 HVGLF HYE IEA IHR INH INR ITC J5H KQ8 NTWIH OK1 Q2X R53 VH1 W8F WOQ ZGI ZXP AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY PQGLB ADGHP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-b601t-f47e5c160e3d855fb90b78af575ba05cb359ee21f22bcef4fa210b15d301c1943 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 89 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000521111900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0017-5749 1468-3288 |
| IngestDate | Tue Nov 04 01:59:56 EST 2025 Fri Sep 05 07:52:07 EDT 2025 Tue Oct 07 07:32:58 EDT 2025 Tue Oct 07 07:14:20 EDT 2025 Mon Jul 21 06:02:39 EDT 2025 Sat Nov 29 04:04:17 EST 2025 Tue Nov 18 21:28:23 EST 2025 Thu Apr 24 23:10:20 EDT 2025 Thu Apr 24 22:50:15 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | immune landscape colorectal cancer single-cell immunophenotyping innate lymphoid cells mass cytometry tissue-resident memory T cells |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b601t-f47e5c160e3d855fb90b78af575ba05cb359ee21f22bcef4fa210b15d301c1943 |
| Notes | Original article ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4966-7036 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7063399 |
| PMID | 31270164 |
| PQID | 2372615901 |
| PQPubID | 2041069 |
| PageCount | 13 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7063399 proquest_miscellaneous_2252266669 proquest_journals_3176094286 proquest_journals_2372615901 pubmed_primary_31270164 crossref_primary_10_1136_gutjnl_2019_318672 crossref_citationtrail_10_1136_gutjnl_2019_318672 bmj_primary_10_1136_gutjnl_2019_318672 bmj_journals_10_1136_gutjnl_2019_318672 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-04-01 |
| PublicationDateYYYYMMDD | 2020-04-01 |
| PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationSeriesTitle | Original research |
| PublicationTitle | Gut |
| PublicationTitleAbbrev | Gut |
| PublicationTitleAlternate | Gut |
| PublicationYear | 2020 |
| Publisher | BMJ Publishing Group Ltd and British Society of Gastroenterology BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: BMJ Publishing Group Ltd and British Society of Gastroenterology – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | van der Maaten, Hinton (R20) 2008; 9 Simoni, Becht, Fehlings (R23) 2018; 557 Kim, Song, Park (R55) 2018; 155 Rajagopalan, Long (R38) 2012; 3 Kelderman, Schumacher, Kvistborg (R4) 2015; 28 Angelova, Charoentong, Hackl (R27) 2015; 16 Duhen, Duhen, Montler (R22) 2018; 9 Ionov, Peinado, Malkhosyan (R6) 1993; 363 Höllt, Pezzotti, van Unen (R13) 2016; 35 Dierssen, de Miranda, Ferrone (R40) 2007; 7 Topalian, Hodi, Brahmer (R2) 2012; 366 Webb, Milne, Nelson (R45) 2015; 3 Johnson, Li, Rabinovic (R17) 2007; 8 Butler, Hoffman, Smibert (R18) 2018; 36 Abdelaal, van Unen, Höllt (R16) 2019 van Unen, Höllt, Pezzotti (R15) 2017; 8 Wagtmann, Biassoni, Cantoni (R37) 1995; 2 Menon, Janssen-van Rhijn, Morreau (R25) 2004; 84 Middha, Yaeger, Shia (R56) 2019; 3 Galon, Costes, Sanchez-Cabo (R26) 2006; 313 de Miranda, Goudkade, Jordanova (R9) 2012; 18 Chevrier, Levine, Zanotelli (R10) 2017; 169 Fergusson, Hühn, Swadling (R52) 2016; 9 Djenidi, Adam, Goubar (R46) 2015; 194 Burris, Callahan, Tolcher (R50) 2017; 35 Santegoets, van Ham, Ehsan (R48) 2019; 25 Li, van Unen, Höllt (R24) 2018; 215 Li, Courtois, Sengupta (R29) 2017; 49 (R7) 2012; 487 Dadi, Chhangawala, Whitlock (R34) 2016; 164 Guinney, Dienstmann, Wang (R28) 2015; 21 Fergusson, Smith, Fleming (R51) 2014; 9 Edwards, Wilmott, Madore (R47) 2018; 24 Bendall, Nolan, Roederer (R33) 2012; 33 Simoni, Fehlings, Kløverpris (R36) 2017; 46 Kansy, Concha-Benavente, Srivastava (R54) 2017; 77 Hodi, O’Day, McDermott (R1) 2010; 363 Moretta, Vitale, Bottino (R39) 1993; 178 Zheng, Zheng, Yoo (R11) 2017; 169 Smyrk, Watson, Kaul (R8) 2001; 91 Schulz, Zanotelli, Fischer (R31) 2018; 6 Thommen, Koelzer, Herzig (R53) 2018; 24 Hutloff, Dittrich, Beier (R49) 1999; 397 Pezzotti, Höllt, Lelieveldt (R14) 2016; 35 Kloor, Becker, Benner (R41) 2005; 65 Peterson, Zhang, Kumar (R30) 2017; 35 Iwasaki, Tanaka, Kobayashi (R43) 2011; 41 Kotecha, Krutzik, Irish (R12) 2010; Chapter 10 Fuchs, Vermi, Lee (R35) 2013; 38 Rizvi, Hellmann, Snyder (R3) 2015; 348 Ijsselsteijn, Petitprez, Lacroix (R42) 2019; 120 Webb, Milne, Watson (R44) 2014; 20 Ijsselsteijn, Brouwer, Abdulrahman (R21) 2019; 5 Waltman, van Eck (R19) 2013; 86 Bandura, Baranov, Ornatsky (R32) 2009; 81 Le, Durham, Smith (R5) 2017; 357 Webb, Milne, Watson 2014; 20 Bendall, Nolan, Roederer 2012; 33 Kelderman, Schumacher, Kvistborg 2015; 28 2012; 487 Rajagopalan, Long 2012; 3 Fuchs, Vermi, Lee 2013; 38 Kansy, Concha-Benavente, Srivastava 2017; 77 Simoni, Fehlings, Kløverpris 2017; 46 Djenidi, Adam, Goubar 2015; 194 Zheng, Zheng, Yoo 2017; 169 Moretta, Vitale, Bottino 1993; 178 Kotecha, Krutzik, Irish 2010; Chapter 10 Dierssen, de Miranda, Ferrone 2007; 7 Edwards, Wilmott, Madore 2018; 24 Iwasaki, Tanaka, Kobayashi 2011; 41 Menon, Janssen-van Rhijn, Morreau 2004; 84 Dadi, Chhangawala, Whitlock 2016; 164 Fergusson, Smith, Fleming 2014; 9 Höllt, Pezzotti, van Unen 2016; 35 Hutloff, Dittrich, Beier 1999; 397 Thommen, Koelzer, Herzig 2018; 24 Simoni, Becht, Fehlings 2018; 557 Smyrk, Watson, Kaul 2001; 91 Li, van Unen, Höllt 2018; 215 Peterson, Zhang, Kumar 2017; 35 Kloor, Becker, Benner 2005; 65 Galon, Costes, Sanchez-Cabo 2006; 313 Bandura, Baranov, Ornatsky 2009; 81 Abdelaal, van Unen, Höllt 2019 Guinney, Dienstmann, Wang 2015; 21 Topalian, Hodi, Brahmer 2012; 366 Ionov, Peinado, Malkhosyan 1993; 363 Ijsselsteijn, Petitprez, Lacroix 2019; 120 Schulz, Zanotelli, Fischer 2018; 6 van Unen, Höllt, Pezzotti 2017; 8 Johnson, Li, Rabinovic 2007; 8 Wagtmann, Biassoni, Cantoni 1995; 2 Ijsselsteijn, Brouwer, Abdulrahman 2019; 5 Li, Courtois, Sengupta 2017; 49 Webb, Milne, Nelson 2015; 3 Rizvi, Hellmann, Snyder 2015; 348 Fergusson, Hühn, Swadling 2016; 9 Duhen, Duhen, Montler 2018; 9 Santegoets, van Ham, Ehsan 2019; 25 Kim, Song, Park 2018; 155 Waltman, van Eck 2013; 86 Chevrier, Levine, Zanotelli 2017; 169 Pezzotti, Höllt, Lelieveldt 2016; 35 Middha, Yaeger, Shia 2019; 3 de Miranda, Goudkade, Jordanova 2012; 18 Hodi, O’Day, McDermott 2010; 363 Butler, Hoffman, Smibert 2018; 36 Burris, Callahan, Tolcher 2017; 35 van der Maaten, Hinton 2008; 9 Angelova, Charoentong, Hackl 2015; 16 Le, Durham, Smith 2017; 357 2024111023102747000_69.4.691.43 2024111023102747000_69.4.691.44 2024111023102747000_69.4.691.41 2024111023102747000_69.4.691.42 Middha (2024111023102747000_69.4.691.56) 2019; 3 2024111023102747000_69.4.691.49 2024111023102747000_69.4.691.47 2024111023102747000_69.4.691.48 2024111023102747000_69.4.691.45 2024111023102747000_69.4.691.46 2024111023102747000_69.4.691.10 2024111023102747000_69.4.691.54 2024111023102747000_69.4.691.11 2024111023102747000_69.4.691.55 2024111023102747000_69.4.691.52 2024111023102747000_69.4.691.53 2024111023102747000_69.4.691.50 2024111023102747000_69.4.691.51 2024111023102747000_69.4.691.18 Dierssen (2024111023102747000_69.4.691.40) 2007; 7 2024111023102747000_69.4.691.19 2024111023102747000_69.4.691.16 2024111023102747000_69.4.691.17 2024111023102747000_69.4.691.14 2024111023102747000_69.4.691.15 2024111023102747000_69.4.691.13 2024111023102747000_69.4.691.21 2024111023102747000_69.4.691.22 2024111023102747000_69.4.691.20 Kotecha (2024111023102747000_69.4.691.12) 2010; Chapter 10 2024111023102747000_69.4.691.1 2024111023102747000_69.4.691.2 2024111023102747000_69.4.691.3 2024111023102747000_69.4.691.4 2024111023102747000_69.4.691.5 2024111023102747000_69.4.691.6 2024111023102747000_69.4.691.7 2024111023102747000_69.4.691.29 2024111023102747000_69.4.691.8 2024111023102747000_69.4.691.9 2024111023102747000_69.4.691.27 2024111023102747000_69.4.691.28 2024111023102747000_69.4.691.25 2024111023102747000_69.4.691.26 2024111023102747000_69.4.691.23 2024111023102747000_69.4.691.24 2024111023102747000_69.4.691.32 2024111023102747000_69.4.691.33 2024111023102747000_69.4.691.30 2024111023102747000_69.4.691.31 2024111023102747000_69.4.691.38 2024111023102747000_69.4.691.39 2024111023102747000_69.4.691.36 2024111023102747000_69.4.691.37 2024111023102747000_69.4.691.34 2024111023102747000_69.4.691.35 32139551 - Gut. 2020 Dec;69(12):2261-2263 |
| References_xml | – volume: 169 start-page: 736 year: 2017 ident: R10 article-title: An Immune Atlas of Clear Cell Renal Cell Carcinoma publication-title: Cell doi: 10.1016/j.cell.2017.04.016 – volume: 18 start-page: 1237 year: 2012 ident: R9 article-title: Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-11-1997 – volume: 24 start-page: 3036 year: 2018 ident: R47 article-title: CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2257 – volume: 557 start-page: 575 year: 2018 ident: R23 article-title: Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates publication-title: Nature doi: 10.1038/s41586-018-0130-2 – volume: 35 start-page: 936 year: 2017 ident: R30 article-title: Multiplexed quantification of proteins and transcripts in single cells publication-title: Nat Biotechnol doi: 10.1038/nbt.3973 – volume: 3 start-page: 926 year: 2015 ident: R45 article-title: PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-14-0239 – volume: 33 start-page: 323 year: 2012 ident: R33 article-title: A deep profiler’s guide to cytometry publication-title: Trends Immunol doi: 10.1016/j.it.2012.02.010 – volume: 35 start-page: 171 year: 2016 ident: R13 article-title: Cytosplore: Interactive Immune Cell Phenotyping for Large Single-Cell Datasets publication-title: Computer Graphics Forum doi: 10.1111/cgf.12893 – volume: 357 start-page: 409 year: 2017 ident: R5 article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade publication-title: Science doi: 10.1126/science.aan6733 – volume: 178 start-page: 597 year: 1993 ident: R39 article-title: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities publication-title: J Exp Med doi: 10.1084/jem.178.2.597 – volume: Chapter 10 start-page: 10.17.1 year: 2010 ident: R12 article-title: Web-based analysis and publication of flow cytometry experiments publication-title: Curr Protoc Cytom doi: 10.1002/0471142956.cy1017s53 – year: 2019 ident: R16 article-title: Predicting cell populations in single cell mass cytometry data publication-title: Cytometry A doi: 10.1002/cyto.a.23738 – volume: 2 start-page: 439 year: 1995 ident: R37 article-title: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains publication-title: Immunity doi: 10.1016/1074-7613(95)90025-X – volume: 9 start-page: 2579 year: 2008 ident: R20 article-title: Visualizing high-dimensional data using t-SNE publication-title: J Mach Learn Res – volume: 21 start-page: 1350 year: 2015 ident: R28 article-title: The consensus molecular subtypes of colorectal cancer publication-title: Nat Med doi: 10.1038/nm.3967 – volume: 9 start-page: 1075 year: 2014 ident: R51 article-title: CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages publication-title: Cell Rep doi: 10.1016/j.celrep.2014.09.045 – volume: 28 start-page: 11 year: 2015 ident: R4 article-title: Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.06.012 – volume: 487 start-page: 330 year: 2012 ident: R7 article-title: Comprehensive molecular characterization of human colon and rectal cancer publication-title: Nature doi: 10.1038/nature11252 – volume: 9 start-page: 401 year: 2016 ident: R52 article-title: CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut publication-title: Mucosal Immunol doi: 10.1038/mi.2015.69 – volume: 3 start-page: 1 year: 2019 ident: R56 article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High publication-title: JCO Precis Oncol doi: 10.1200/PO.18.00321 – volume: 35 start-page: 3033 issue: 15_suppl year: 2017 ident: R50 article-title: Phase 1 safety of ICOS agonist antibody JTX-2011 alone and with nivolumab (nivo) in advanced solid tumors; predicted vs observed pharmacokinetics (PK) in ICONIC publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2017.35.15_suppl.3033 – volume: 25 start-page: 240 year: 2019 ident: R48 article-title: The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-18-1749 – volume: 38 start-page: 769 year: 2013 ident: R35 article-title: Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells publication-title: Immunity doi: 10.1016/j.immuni.2013.02.010 – volume: 194 start-page: 3475 year: 2015 ident: R46 article-title: CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients publication-title: J Immunol doi: 10.4049/jimmunol.1402711 – volume: 91 start-page: 2417 year: 2001 ident: R8 article-title: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma publication-title: Cancer doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U – volume: 46 start-page: 148 year: 2017 ident: R36 article-title: Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency publication-title: Immunity doi: 10.1016/j.immuni.2016.11.005 – volume: 120 start-page: 815 year: 2019 ident: R42 article-title: Revisiting immune escape in colorectal cancer in the era of immunotherapy publication-title: Br J Cancer doi: 10.1038/s41416-019-0421-x – volume: 35 start-page: 21 year: 2016 ident: R14 article-title: Hierarchical Stochastic Neighbor Embedding publication-title: Computer Graphics Forum doi: 10.1111/cgf.12878 – volume: 7 year: 2007 ident: R40 article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression publication-title: BMC Cancer doi: 10.1186/1471-2407-7-33 – volume: 16 start-page: 64 year: 2015 ident: R27 article-title: Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy publication-title: Genome Biol doi: 10.1186/s13059-015-0620-6 – volume: 24 start-page: 994 year: 2018 ident: R53 article-title: A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade publication-title: Nat Med doi: 10.1038/s41591-018-0057-z – volume: 6 start-page: 25 year: 2018 ident: R31 article-title: Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry publication-title: Cell Syst doi: 10.1016/j.cels.2017.12.001 – volume: 77 start-page: 6353 year: 2017 ident: R54 article-title: PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-3167 – volume: 348 start-page: 124 year: 2015 ident: R3 article-title: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer publication-title: Science doi: 10.1126/science.aaa1348 – volume: 5 start-page: 3 year: 2019 ident: R21 article-title: Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification publication-title: J Pathol Clin Res doi: 10.1002/cjp2.113 – volume: 313 start-page: 1960 year: 2006 ident: R26 article-title: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome publication-title: Science doi: 10.1126/science.1129139 – volume: 164 start-page: 365 year: 2016 ident: R34 article-title: Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells publication-title: Cell doi: 10.1016/j.cell.2016.01.002 – volume: 65 start-page: 6418 year: 2005 ident: R41 article-title: Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0044 – volume: 397 start-page: 263 year: 1999 ident: R49 article-title: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 publication-title: Nature doi: 10.1038/16717 – volume: 36 start-page: 411 year: 2018 ident: R18 article-title: Integrating single-cell transcriptomic data across different conditions, technologies, and species publication-title: Nat Biotechnol doi: 10.1038/nbt.4096 – volume: 8 start-page: 118 year: 2007 ident: R17 article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods publication-title: Biostatistics doi: 10.1093/biostatistics/kxj037 – volume: 49 start-page: 708 year: 2017 ident: R29 article-title: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors publication-title: Nat Genet doi: 10.1038/ng.3818 – volume: 363 start-page: 711 year: 2010 ident: R1 article-title: Improved survival with ipilimumab in patients with metastatic melanoma publication-title: N Engl J Med doi: 10.1056/NEJMoa1003466 – volume: 9 start-page: 2724 year: 2018 ident: R22 article-title: Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors publication-title: Nat Commun doi: 10.1038/s41467-018-05072-0 – volume: 84 start-page: 493 year: 2004 ident: R25 article-title: Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis publication-title: Lab Invest doi: 10.1038/labinvest.3700055 – volume: 215 start-page: 1383 year: 2018 ident: R24 article-title: Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine publication-title: J Exp Med doi: 10.1084/jem.20171934 – volume: 169 start-page: 1342 year: 2017 ident: R11 article-title: Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing publication-title: Cell doi: 10.1016/j.cell.2017.05.035 – volume: 3 start-page: 258 year: 2012 ident: R38 article-title: KIR2DL4 (CD158d): An activation receptor for HLA-G publication-title: Front Immunol doi: 10.3389/fimmu.2012.00258 – volume: 41 start-page: 345 year: 2011 ident: R43 article-title: Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens publication-title: Eur J Immunol doi: 10.1002/eji.201040959 – volume: 155 start-page: 1936 year: 2018 ident: R55 article-title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.030 – volume: 8 start-page: 1740 year: 2017 ident: R15 article-title: Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types publication-title: Nat Commun doi: 10.1038/s41467-017-01689-9 – volume: 86 start-page: 471 year: 2013 ident: R19 article-title: A smart local moving algorithm for large-scale modularity-based community detection publication-title: Eur Phys J B doi: 10.1140/epjb/e2013-40829-0 – volume: 363 start-page: 558 year: 1993 ident: R6 article-title: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis publication-title: Nature doi: 10.1038/363558a0 – volume: 20 start-page: 434 year: 2014 ident: R44 article-title: Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-1877 – volume: 366 start-page: 2443 year: 2012 ident: R2 article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1200690 – volume: 81 start-page: 6813 year: 2009 ident: R32 article-title: Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry publication-title: Anal Chem doi: 10.1021/ac901049w – volume: 363 start-page: 711 year: 2010 article-title: Improved survival with ipilimumab in patients with metastatic melanoma publication-title: N Engl J Med doi: 10.1056/NEJMoa1003466 – volume: 164 start-page: 365 year: 2016 article-title: Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells publication-title: Cell doi: 10.1016/j.cell.2016.01.002 – year: 2019 article-title: Predicting cell populations in single cell mass cytometry data publication-title: Cytometry A doi: 10.1002/cyto.a.23738 – volume: 33 start-page: 323 year: 2012 article-title: A deep profiler’s guide to cytometry publication-title: Trends Immunol doi: 10.1016/j.it.2012.02.010 – volume: 155 start-page: 1936 year: 2018 article-title: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.030 – volume: 169 start-page: 736 year: 2017 article-title: An Immune Atlas of Clear Cell Renal Cell Carcinoma publication-title: Cell doi: 10.1016/j.cell.2017.04.016 – volume: 35 start-page: 171 year: 2016 article-title: Cytosplore: Interactive Immune Cell Phenotyping for Large Single-Cell Datasets publication-title: Computer Graphics Forum doi: 10.1111/cgf.12893 – volume: 25 start-page: 240 year: 2019 article-title: The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-18-1749 – volume: 86 start-page: 471 year: 2013 article-title: A smart local moving algorithm for large-scale modularity-based community detection publication-title: Eur Phys J B doi: 10.1140/epjb/e2013-40829-0 – volume: 194 start-page: 3475 year: 2015 article-title: CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients publication-title: J Immunol doi: 10.4049/jimmunol.1402711 – volume: 28 start-page: 11 year: 2015 article-title: Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.06.012 – volume: 3 start-page: 1 year: 2019 article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High publication-title: JCO Precis Oncol doi: 10.1200/PO.18.00321 – volume: 21 start-page: 1350 year: 2015 article-title: The consensus molecular subtypes of colorectal cancer publication-title: Nat Med doi: 10.1038/nm.3967 – volume: 35 start-page: 936 year: 2017 article-title: Multiplexed quantification of proteins and transcripts in single cells publication-title: Nat Biotechnol doi: 10.1038/nbt.3973 – volume: 9 start-page: 1075 year: 2014 article-title: CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages publication-title: Cell Rep doi: 10.1016/j.celrep.2014.09.045 – volume: 65 start-page: 6418 year: 2005 article-title: Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0044 – volume: 5 start-page: 3 year: 2019 article-title: Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification publication-title: J Pathol Clin Res doi: 10.1002/cjp2.113 – volume: 46 start-page: 148 year: 2017 article-title: Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency publication-title: Immunity doi: 10.1016/j.immuni.2016.11.005 – volume: 77 start-page: 6353 year: 2017 article-title: PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-16-3167 – volume: 2 start-page: 439 year: 1995 article-title: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains publication-title: Immunity doi: 10.1016/1074-7613(95)90025-X – volume: 366 start-page: 2443 year: 2012 article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1200690 – volume: 91 start-page: 2417 year: 2001 article-title: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma publication-title: Cancer doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U – volume: 357 start-page: 409 year: 2017 article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade publication-title: Science doi: 10.1126/science.aan6733 – volume: 81 start-page: 6813 year: 2009 article-title: Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry publication-title: Anal Chem doi: 10.1021/ac901049w – volume: 35 start-page: 3033 issue: 15_suppl year: 2017 article-title: Phase 1 safety of ICOS agonist antibody JTX-2011 alone and with nivolumab (nivo) in advanced solid tumors; predicted vs observed pharmacokinetics (PK) in ICONIC publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2017.35.15_suppl.3033 – volume: 8 start-page: 118 year: 2007 article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods publication-title: Biostatistics doi: 10.1093/biostatistics/kxj037 – volume: 38 start-page: 769 year: 2013 article-title: Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells publication-title: Immunity doi: 10.1016/j.immuni.2013.02.010 – volume: 363 start-page: 558 year: 1993 article-title: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis publication-title: Nature doi: 10.1038/363558a0 – volume: 348 start-page: 124 year: 2015 article-title: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer publication-title: Science doi: 10.1126/science.aaa1348 – volume: 557 start-page: 575 year: 2018 article-title: Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates publication-title: Nature doi: 10.1038/s41586-018-0130-2 – volume: 178 start-page: 597 year: 1993 article-title: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities publication-title: J Exp Med doi: 10.1084/jem.178.2.597 – volume: 9 start-page: 2579 year: 2008 article-title: Visualizing high-dimensional data using t-SNE publication-title: J Mach Learn Res – volume: 84 start-page: 493 year: 2004 article-title: Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis publication-title: Lab Invest doi: 10.1038/labinvest.3700055 – volume: 6 start-page: 25 year: 2018 article-title: Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry publication-title: Cell Syst doi: 10.1016/j.cels.2017.12.001 – volume: 7 year: 2007 article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression publication-title: BMC Cancer doi: 10.1186/1471-2407-7-33 – volume: Chapter 10 start-page: 10.17.1 year: 2010 article-title: Web-based analysis and publication of flow cytometry experiments publication-title: Curr Protoc Cytom doi: 10.1002/0471142956.cy1017s53 – volume: 36 start-page: 411 year: 2018 article-title: Integrating single-cell transcriptomic data across different conditions, technologies, and species publication-title: Nat Biotechnol doi: 10.1038/nbt.4096 – volume: 24 start-page: 994 year: 2018 article-title: A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade publication-title: Nat Med doi: 10.1038/s41591-018-0057-z – volume: 487 start-page: 330 year: 2012 article-title: Comprehensive molecular characterization of human colon and rectal cancer publication-title: Nature doi: 10.1038/nature11252 – volume: 24 start-page: 3036 year: 2018 article-title: CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2257 – volume: 49 start-page: 708 year: 2017 article-title: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors publication-title: Nat Genet doi: 10.1038/ng.3818 – volume: 215 start-page: 1383 year: 2018 article-title: Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine publication-title: J Exp Med doi: 10.1084/jem.20171934 – volume: 18 start-page: 1237 year: 2012 article-title: Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-11-1997 – volume: 9 start-page: 2724 year: 2018 article-title: Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors publication-title: Nat Commun doi: 10.1038/s41467-018-05072-0 – volume: 35 start-page: 21 year: 2016 article-title: Hierarchical Stochastic Neighbor Embedding publication-title: Computer Graphics Forum doi: 10.1111/cgf.12878 – volume: 169 start-page: 1342 year: 2017 article-title: Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing publication-title: Cell doi: 10.1016/j.cell.2017.05.035 – volume: 8 start-page: 1740 year: 2017 article-title: Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types publication-title: Nat Commun doi: 10.1038/s41467-017-01689-9 – volume: 20 start-page: 434 year: 2014 article-title: Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-1877 – volume: 41 start-page: 345 year: 2011 article-title: Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens publication-title: Eur J Immunol doi: 10.1002/eji.201040959 – volume: 9 start-page: 401 year: 2016 article-title: CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut publication-title: Mucosal Immunol doi: 10.1038/mi.2015.69 – volume: 16 start-page: 64 year: 2015 article-title: Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy publication-title: Genome Biol doi: 10.1186/s13059-015-0620-6 – volume: 313 start-page: 1960 year: 2006 article-title: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome publication-title: Science doi: 10.1126/science.1129139 – volume: 3 start-page: 258 year: 2012 article-title: KIR2DL4 (CD158d): An activation receptor for HLA-G publication-title: Front Immunol doi: 10.3389/fimmu.2012.00258 – volume: 120 start-page: 815 year: 2019 article-title: Revisiting immune escape in colorectal cancer in the era of immunotherapy publication-title: Br J Cancer doi: 10.1038/s41416-019-0421-x – volume: 3 start-page: 926 year: 2015 article-title: PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-14-0239 – volume: 397 start-page: 263 year: 1999 article-title: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 publication-title: Nature doi: 10.1038/16717 – ident: 2024111023102747000_69.4.691.34 doi: 10.1016/j.cell.2016.01.002 – ident: 2024111023102747000_69.4.691.46 doi: 10.4049/jimmunol.1402711 – ident: 2024111023102747000_69.4.691.48 doi: 10.1158/1078-0432.CCR-18-1749 – ident: 2024111023102747000_69.4.691.49 doi: 10.1038/16717 – ident: 2024111023102747000_69.4.691.43 doi: 10.1002/eji.201040959 – ident: 2024111023102747000_69.4.691.47 doi: 10.1158/1078-0432.CCR-17-2257 – ident: 2024111023102747000_69.4.691.16 doi: 10.1101/316034 – ident: 2024111023102747000_69.4.691.4 doi: 10.1016/j.ccell.2015.06.012 – ident: 2024111023102747000_69.4.691.18 doi: 10.1038/nbt.4096 – ident: 2024111023102747000_69.4.691.50 doi: 10.1200/JCO.2017.35.15_suppl.3033 – ident: 2024111023102747000_69.4.691.27 doi: 10.1186/s13059-015-0620-6 – ident: 2024111023102747000_69.4.691.22 doi: 10.1038/s41467-018-05072-0 – volume: 7 year: 2007 ident: 2024111023102747000_69.4.691.40 article-title: HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression publication-title: BMC Cancer doi: 10.1186/1471-2407-7-33 – ident: 2024111023102747000_69.4.691.25 doi: 10.1038/labinvest.3700055 – ident: 2024111023102747000_69.4.691.51 doi: 10.1016/j.celrep.2014.09.045 – volume: Chapter 10 start-page: 10.17.1 year: 2010 ident: 2024111023102747000_69.4.691.12 article-title: Web-based analysis and publication of flow cytometry experiments publication-title: Curr Protoc Cytom – ident: 2024111023102747000_69.4.691.33 doi: 10.1016/j.it.2012.02.010 – ident: 2024111023102747000_69.4.691.38 doi: 10.3389/fimmu.2012.00258 – ident: 2024111023102747000_69.4.691.44 doi: 10.1158/1078-0432.CCR-13-1877 – ident: 2024111023102747000_69.4.691.54 doi: 10.1158/0008-5472.CAN-16-3167 – ident: 2024111023102747000_69.4.691.7 doi: 10.1038/nature11252 – ident: 2024111023102747000_69.4.691.42 doi: 10.1038/s41416-019-0421-x – ident: 2024111023102747000_69.4.691.30 doi: 10.1038/nbt.3973 – ident: 2024111023102747000_69.4.691.15 doi: 10.1038/s41467-017-01689-9 – ident: 2024111023102747000_69.4.691.1 doi: 10.1056/NEJMoa1003466 – ident: 2024111023102747000_69.4.691.9 doi: 10.1158/1078-0432.CCR-11-1997 – ident: 2024111023102747000_69.4.691.37 doi: 10.1016/1074-7613(95)90025-X – ident: 2024111023102747000_69.4.691.8 doi: 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U – ident: 2024111023102747000_69.4.691.13 doi: 10.1111/cgf.12893 – ident: 2024111023102747000_69.4.691.6 doi: 10.1038/363558a0 – ident: 2024111023102747000_69.4.691.10 doi: 10.1016/j.cell.2017.04.016 – ident: 2024111023102747000_69.4.691.53 doi: 10.1038/s41591-018-0057-z – ident: 2024111023102747000_69.4.691.3 doi: 10.1126/science.aaa1348 – ident: 2024111023102747000_69.4.691.31 doi: 10.1016/j.cels.2017.12.001 – ident: 2024111023102747000_69.4.691.14 doi: 10.1111/cgf.12878 – ident: 2024111023102747000_69.4.691.23 doi: 10.1038/s41586-018-0130-2 – ident: 2024111023102747000_69.4.691.20 doi: 10.1007/s10479-011-0841-3 – ident: 2024111023102747000_69.4.691.39 doi: 10.1084/jem.178.2.597 – volume: 3 start-page: 1 year: 2019 ident: 2024111023102747000_69.4.691.56 article-title: Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High publication-title: JCO Precis Oncol doi: 10.1200/PO.18.00321 – ident: 2024111023102747000_69.4.691.19 doi: 10.1140/epjb/e2013-40829-0 – ident: 2024111023102747000_69.4.691.45 doi: 10.1158/2326-6066.CIR-14-0239 – ident: 2024111023102747000_69.4.691.36 doi: 10.1016/j.immuni.2016.11.005 – ident: 2024111023102747000_69.4.691.17 doi: 10.1093/biostatistics/kxj037 – ident: 2024111023102747000_69.4.691.2 doi: 10.1056/NEJMoa1200690 – ident: 2024111023102747000_69.4.691.32 doi: 10.1021/ac901049w – ident: 2024111023102747000_69.4.691.21 doi: 10.1002/cjp2.113 – ident: 2024111023102747000_69.4.691.35 doi: 10.1016/j.immuni.2013.02.010 – ident: 2024111023102747000_69.4.691.24 doi: 10.1084/jem.20171934 – ident: 2024111023102747000_69.4.691.28 doi: 10.1038/nm.3967 – ident: 2024111023102747000_69.4.691.29 doi: 10.1038/ng.3818 – ident: 2024111023102747000_69.4.691.5 doi: 10.1126/science.aan6733 – ident: 2024111023102747000_69.4.691.52 doi: 10.1038/mi.2015.69 – ident: 2024111023102747000_69.4.691.26 doi: 10.1126/science.1129139 – ident: 2024111023102747000_69.4.691.11 doi: 10.1016/j.cell.2017.05.035 – ident: 2024111023102747000_69.4.691.41 doi: 10.1158/0008-5472.CAN-05-0044 – ident: 2024111023102747000_69.4.691.55 doi: 10.1053/j.gastro.2018.08.030 – reference: 32139551 - Gut. 2020 Dec;69(12):2261-2263 |
| SSID | ssj0008891 |
| Score | 2.59787 |
| Snippet | ObjectiveA comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We... A comprehensive understanding of anticancer immune responses is paramount for the optimal application and development of cancer immunotherapies. We unravelled... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 691 |
| SubjectTerms | Antibodies Antigens, CD - metabolism Cancer Cancer immunotherapy Cancer therapies Case-Control Studies CD103 antigen CD38 antigen CD56 antigen CD69 antigen CD7 antigen CD8 Antigens - metabolism Cells Clustering Colon Colonic Neoplasms - immunology Colonic Neoplasms - metabolism Colonic Neoplasms - pathology Colorectal cancer Colorectal carcinoma Cytotoxicity Flow Cytometry Genomics GI cancer Histocompatibility antigen HLA Humans immune landscape Immunity Immunofluorescence Immunogenicity Immunoglobulins Immunotherapy innate lymphoid cells Integrin alpha Chains - metabolism Lymph nodes Lymphatic system Lymphocyte Count Lymphocytes Lymphocytes T Lymphocytes, Tumor-Infiltrating mass cytometry Medical research Metastases Mismatch repair Mucosa Mutation Patients PD-1 protein Peripheral blood Phenotypes Principal components analysis Ribonucleic acid RNA single-cell immunophenotyping tissue-resident memory T cells Transcription Tumors |
| Title | High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity |
| URI | https://gut.bmj.com/content/early/2019/07/03/gutjnl-2019-318672.full https://gut.bmj.com/content/69/4/691.full https://www.ncbi.nlm.nih.gov/pubmed/31270164 https://www.proquest.com/docview/2372615901 https://www.proquest.com/docview/3176094286 https://www.proquest.com/docview/2252266669 https://pubmed.ncbi.nlm.nih.gov/PMC7063399 |
| Volume | 69 |
| WOSCitedRecordID | wos000521111900011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1468-3288 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0008891 issn: 0017-5749 databaseCode: M7P dateStart: 19600301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库 customDbUrl: eissn: 1468-3288 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0008891 issn: 0017-5749 databaseCode: 7X7 dateStart: 19600301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-3288 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0008891 issn: 0017-5749 databaseCode: BENPR dateStart: 19600301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database (subscription) customDbUrl: eissn: 1468-3288 dateEnd: 20250607 omitProxy: false ssIdentifier: ssj0008891 issn: 0017-5749 databaseCode: M2P dateStart: 19600301 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED7RDiFe-A0rjMlICB5QtMaJY_sJAdrEA6sqBFLfothxWKc22dp00v577hIno4AqJPoQqbITu73z5Tv77juA19xmibCZCxDbZkFscrSDMteB0lJYK4RKTCPpL3IyUbOZnvoNt7UPq-xsYmOo88rSHvkRjySCfcqUfH9xGVDVKDpd9SU0BrBHTGXxEPY-Hk-mX3tbrLqaeWiLhYx1lzYTJUc_NvV5uUAtCTWlECfEETwwy_PtF9QfqPP34Mlf3kYn9__3dzyAex6Hsg-t4jyEW658BHdO_Un7YzijAJAgJ-7_lreD2eu6WlL9Lcsyz2TCqoIR6zVZTepBGrRiRAqFSs3K6sotWJOaQiV9qHNGScGbJQ7O5k1iSn39BL6fHH_79DnwVRkCg85bHRSxdMKGydhFuRKiMHpspMoKxH0mGwtrIqGd42HBubGuiIsMvUoTihxNiUUZRU9hWFal2weG7opWiPGkIm71PDeJ42OrcBgV4UP1CN6iQFK_qtZp47BESdqKLiXRpa3oRvCGel60DB07O4addFPrWdCpGMdi5z3v-nv-ZYSDTvA3M7-R-l-bEcQl6GdzlYzgVd-MC51Ob7LSVRt8BCeojB_8W561KtjPJqL4AXR8RyC3lLPvQCTi2y3l_KwhE5eIURGkPt896xdwl9NGQxOydADDerVxL-G2varn69UhDORMNld16FcgfjvlU7rK6U_zFDm3 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61BQEX3o9AgUXicUBW7XXW6z0ghICqVdOIQ5FyM7vrNU2V2CVxivKn-I3M-FUCKOLSA7nueHdjz8zOZ898A_CcWx0Jq52Hsa32-iZFPyhT5cVKCmuFiCNTPemBHA7j0Uh92oAfbS0MpVW2PrFy1Glh6R35Dg8lBvtUKfn29JtHXaPo62rbQqNWiwO3_I6Qbf5m_wM-3xec7348er_nNV0FPIPgo_SyvnTCBpHvwjQWIjPKNzLWGcYtRvvCmlAo53iQcW6sy_qZRlRkApGiKViE_CHOuwmX0I9LSiGTow7gUcZQ0Hp-IfuqLdIJo52vi_Ikn6BOBooKliNiJN4005PV4_CPGPf3VM1fzr7dG__bXbsJ15som72rzeIWbLj8Nlw5bPII7sAxpbd4KXU2qFlJmF2WxZS6i1mmG54WVmSMOL3pTCAJso8ZI8orNFmWF2duwqrCG2pYRMKaSp4XU1ycjauym3J5Fz5fyP-8B1t5kbsHwBCMqRgjWBkTc3yamshx38a4TBzipKoHr1ABksZnzJMKjoVRUqtKQqqS1KrSg5ckeVrzj6wVDFptSmzD8U6tRiZrr3ndXfMvK2y3ina-83Mt--swhqiRrxDnRj141g2jG6NvUzp3xQKn4AQE8Ie35X6t8t1uQsqOQFjfA7liDJ0AUaSvjuTj44oqXWIEjiH4w_W7fgpX944OB8lgf3jwCK5xeqVSJWdtw1Y5W7jHcNmeleP57Ell7wy-XLSp_AQmR5IV |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61BVW98IYGCiwSjwOyYq-93vUBIUSJqNpGOYDUm_Gu1zRVYpfEKcpf49cx41cJoIhLD-S6692N_c3LnvkG4Dk3SShMYh30bRMn0CnqQZlGjoqkMEYIFerqSR_J4VCdnESjDfjR1sJQWmWrEytFnRaG3pH3uS_R2adKyX7WpEWM9gdvz7851EGKvrS27TRqiBza5XcM3-ZvDvbxWb_gfPDh0_uPTtNhwNEYiJROFkgrjBe61k-VEJmOXC1VkqEPoxNXGO2LyFruZZxrY7MgSzBC0p5IUSwMhv8-rrsJ12QgBEnXMR91VkC13frQCggZRG3Bjh_2vy7Ks3yC-PQiKl4OiZ14U0_PVk3jH_7u72mbv9jBwc3_-Q7eghuN983e1eJyGzZsfge2j5v8grtwSmkvTkodD2q2EmaWZTGlrmOGJQ1_CysyRlzfZCtoBsnNjBEVFooyy4sLO2FVQQ41MqLJCZVCL6a4ORtX5Tjl8h58vpL_eR-28iK3u8AwSIsUerZSEaN8murQctco3Eb5uGjUg1cIhrjRJfO4CtP8MK5hExNs4ho2PXhJM89rXpK1E70WWbFpuN-pBclk7TWvu2v-ZYe9FnSXJ79E3F-H0XUN3Qjj37AHz7phVG_0zSrJbbHAJTgFCPjD2_Kghn93Gp-yJjDc74FcEYxuAlGnr47k49OKQl2iZ46u-cP1p34K2ygh8dHB8PAR7HB601LlbO3BVjlb2Mdw3VyU4_nsSSX6DL5ctaT8BLAFmuI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-dimensional+cytometric+analysis+of+colorectal+cancer+reveals+novel+mediators+of+antitumour+immunity&rft.jtitle=Gut&rft.au=de+Vries%2C+Natasja+L&rft.au=van+Unen%2C+Vincent&rft.au=Ijsselsteijn%2C+Marieke+E&rft.au=Abdelaal%2C+Tamim&rft.date=2020-04-01&rft.issn=0017-5749&rft.eissn=1468-3288&rft.volume=69&rft.issue=4&rft.spage=691&rft.epage=703&rft_id=info:doi/10.1136%2Fgutjnl-2019-318672&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_gutjnl_2019_318672 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-5749&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-5749&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-5749&client=summon |